RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. Founded by Ron Seubert in 2009, RareCyte is backed by investors that include 5AM Ventures, HealthQuest Capital, Ron Seubert, and Telegraph Hill Partners and is headquartered in Seattle.